iCAC Device vs FibriCheck
AI Verdict
Choose iCAC Device if…
Choose iCAC Device if your healthcare system aims to opportunistically screen a broad patient population for cardiovascular disease risk by leveraging existing non-contrast, non-gated chest CT scans. This tool is ideal for identifying early signs of coronary artery calcium from routine imaging, providing valuable adjunctive information to radiologists without requiring additional dedicated scans or patient appointments.
View iCAC Device →Choose FibriCheck if…
Choose FibriCheck if you need a convenient and accessible solution for patients to actively monitor their heart rhythm for arrhythmias, such as Atrial Fibrillation, using their personal smartphone. This app is best suited for remote patient monitoring programs, empowering individuals to track their cardiac health regularly and providing healthcare professionals with a portal to review and manage patient data.
View FibriCheck →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | iCAC Device | FibriCheck |
|---|---|---|
| Pricing | Contact for pricing | Subscription-based, with options for monthly or annual payments. prices vary by region and may be partly or fully covered by insurance or employer. |
| Deployment | Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform). | Cloud-based (private cloud). |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
FibriCheckFibriCheck (Tool B) is a patient-facing mobile application designed for ease of use, with numerous user testimonials highlighting its simplicity and convenience for self-monitoring heart rhythm on a smartphone. While iCAC Device (Tool A) integrates seamlessly into professional radiology workflows, FibriCheck's direct-to-consumer nature and intuitive mobile interface make it more broadly usable for its target audience.
Clinical Value
iCAC DeviceiCAC Device (Tool A) offers significant clinical value by opportunistically detecting and quantifying coronary artery calcium (CAC) from routine, non-contrast chest CT scans, providing early cardiovascular disease risk assessment without additional patient burden. This leverages existing data for population-level risk stratification, a proactive approach to health management. FibriCheck (Tool B) also provides high clinical value by enabling accessible arrhythmia monitoring, but Tool A's ability to derive new, critical insights from already-acquired data for early detection gives it a broader proactive impact.
Pricing & Value
FibriCheckFibriCheck (Tool B) provides transparent and detailed pricing information, including monthly/yearly subscriptions for end-users and specific rates for prescribed patients, making its value proposition clear. In contrast, iCAC Device (Tool A) requires contacting the vendor for pricing, which makes it difficult to assess its cost-effectiveness and overall value without further inquiry.
Enterprise Readiness
iCAC DeviceiCAC Device (Tool A) demonstrates strong enterprise readiness through its explicit integration with PACS, DICOM routers, and EHRs via the Carebricks platform, essential for hospital and radiology workflows. Bunkerhill Health also provides a comprehensive Trust Center detailing HIPAA, SOC 2, and ISO 27001:2022 certifications, along with disaster recovery plans, indicating robust security and operational maturity for enterprise deployment.
Innovation
iCAC DeviceiCAC Device (Tool A) is highly innovative for its ability to opportunistically detect and quantify coronary artery calcium from *routine, non-contrast, non-gated chest CT scans* already performed for other indications. This approach leverages existing imaging data to provide critical cardiovascular risk information without additional patient burden or radiation, representing a significant advancement in proactive health management and resource optimization. While FibriCheck (Tool B) innovates in smartphone-based monitoring, Tool A's method of extracting new value from existing data streams is a more profound innovation in clinical workflow.
Support & Docs
FibriCheckFibriCheck (Tool B) offers transparent and accessible support resources, including a dedicated Help Center with user manuals, FAQs, and clear contact information for support via email. While iCAC Device (Tool A) implies support through its enterprise integrations, specific documentation and direct support channels are not as readily apparent from the available information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | iCAC Device | FibriCheck |
|---|---|---|
| Name | iCAC Device | FibriCheck |
| Description | FDA-cleared AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection. | Medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias using just their smartphone. |
| Primary Detection Focus | Estimates presence and quantity of coronary artery calcium (CAC); analyzes routine, non-contrast, non-gated chest CT scans. | Detection of Atrial Fibrillation (AFib) and other arrhythmias; heart rhythm measurement. |
| Technology Used | Deep-learning algorithms for analysis. | Smartphone camera-based PPG technology for heart rhythm measurement; AI-powered algorithm for arrhythmia detection and analysis. |
| Target User / Monitoring | Provides adjunctive information to radiologists; supports opportunistic identification of CAC from existing CT scans. | Patient-facing mobile application; Healthcare professional portal/dashboard for patient monitoring. |
Videos
Demos, reviews, and walkthroughs featuring iCAC Device and FibriCheck.